Myers, L W <br/><br/>
Immunologic therapy for secondary and primary progressive multiple sclerosis.  [electronic resource] 

 -  Current neurology and neuroscience reports  May 2001 
 - 286-93 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1528-4042 
<br/><br/><label>Standard No.: </label>10.1007/s11910-001-0032-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antilymphocyte Serum--therapeutic use<br/>Autoimmune Diseases--classification<br/>Cladribine--therapeutic use<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Cyclophosphamide--therapeutic use<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Forecasting<br/>Glatiramer Acetate<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon beta-1a<br/>Interferon beta-1b<br/>Interferon-beta--therapeutic use<br/>Middle Aged<br/>Mitoxantrone--therapeutic use<br/>Multicenter Studies as Topic<br/>Multiple Sclerosis--classification<br/>Peptides--therapeutic use<br/>Plasma Exchange<br/>Randomized Controlled Trials as Topic<br/>Steroids<br/>T-Lymphocytes--immunology<br/>Treatment Outcome<br/>Vaccination